LUMO - LUMOS PHARMA, INC.
IEX Last Trade
3.85
0 0%
Share volume: 0
Last Updated: Wed 11 Dec 2024 09:35:09 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.40%
PREVIOUS CLOSE
CHG
CHG%
$3.85
0.50
0.11%
Summary score
18%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
6%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.17%
Return on assets
-9.63%
Return on sales
-597.04%
Return on invested capital
18.29%
Total debt ratio
20.62%
Debt ratio change over timeo
-4.04%
Current Ratio
7.98%
Quick Ratio
0%
Cash Position Ratio
7.22%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.04%
Return on assets
-7.14%
Return on sales
-1752.66%
Return on invested capital
61.16%
Total debt ratio
25.86%
Debt ratio change over timeo
-12.08%
Current Ratio
5.32%
Quick Ratio
0%
Cash Position Ratio
4.55%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.6%
Return on assets
-3.99%
Return on sales
0%
Return on invested capital
13.02%
Total debt ratio
32.37%
Debt ratio change over time
-45.78%
Current Ratio
4.01%
Quick Ratio
0%
Cash Position Ratio
1.71%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-64.37%
Return on assets
-68.82%
Return on sales
-761.6%
Return on invested capital
-160.64%
Total debt ratio
-403.63%
Debt ratio change over time
-4.04%
Current Ratio
-35.03%
Quick Ratio
0%
Cash Position Ratio
-12.81%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LUMO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.17% | -3.05% | 11.55% | 6.27% |
| Return on assets | -9.63% | 3.6% | 3.57% | 5.27% |
| Return on sales | -597.04% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 18.29% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 43% | 78% | 76% |
| Total debt ratio | 20.62% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -4.04% | 6.09% | 6.03% | 1.53% |
| Dept financing | 5% | 50% | 43% | 14% |
| Current Ratio | 5.32% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.55% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 38% | 39% |
| Short-term ratios | LUMO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.04% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.14% | 3.26% | 3.67% | 4.71% |
| Return on sales | -1752.66% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 61.16% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 41% | 72% | 65% |
| Total debt ratio | 25.86% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -12.08% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 5.32% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.55% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 35% | 29% | 50% |